{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T05:51:40Z","timestamp":1655790700397},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.contraception.2005.09.006","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T12:48:02Z","timestamp":1131022082000},"page":"311-314","source":"Crossref","is-referenced-by-count":3,"title":["Skin venous thromboembolism by combined oral contraceptive in a woman with acquired angioedema and Factor V Leiden mutation"],"prefix":"10.1016","volume":"73","author":[{"given":"Mehmet A.","family":"Osmana\u011fao\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bakiye","family":"Okumu\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Bozkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2005.09.006_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0162-3109(96)00085-9","article-title":"Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema","volume":"33","author":"Nielsen","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.contraception.2005.09.006_bib2","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.161.20.2417","article-title":"Hereditary angioedema: a broad review for clinicians","volume":"161","author":"Nzeako","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2005.09.006_bib3","first-page":"762","article-title":"Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives","volume":"96","author":"Gordon","year":"1980","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.contraception.2005.09.006_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1440-0960.1992.tb00050.x","article-title":"Hormonally exacerbated hereditary angioedema","volume":"33","author":"Yip","year":"1992","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.contraception.2005.09.006_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.contraception.2005.09.006_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000018252","article-title":"Acquired angioedema with C1 inhibitor deficiency: is the distinction between type I and type II still relevant?","volume":"199","author":"D'Incan","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.contraception.2005.09.006_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.contraception.2005.09.006_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","article-title":"Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study","volume":"342","author":"Koster","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.09.006_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7326\/0003-4819-132-2-200001180-00009","article-title":"Acquired C1 esterase inhibitor deficiency","volume":"132","author":"Markovic","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2005.09.006_bib10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","article-title":"Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate","volume":"334","author":"Waytes","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2005.09.006_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.09.006_bib12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0091-6749(87)80277-4","article-title":"Hereditary angioedema: a decade of management with stanozolol","volume":"80","author":"Sheffer","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.contraception.2005.09.006_bib13","first-page":"397","article-title":"Angioneurotic edema with acquired C1-inhibitor deficiency and autoantibody to C1-inhibitor: response to plasmapheresis and cytotoxic therapy","volume":"119","author":"Donaldson","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.contraception.2005.09.006_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM197204132861503","article-title":"Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study","volume":"286","author":"Frank","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2005.09.006_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0033-0620(94)80051-0","article-title":"The natural history and epidemiology of venous thrombosis","volume":"36","author":"Carter","year":"1994","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.contraception.2005.09.006_bib16","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.09.006_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2005.09.006_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.006_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.09.006_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405003574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405003574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T10:54:03Z","timestamp":1548068043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782405003574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0010782405003574"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2005.09.006","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}